Details for Patent: 8,846,091

Summary for Patent: 8,846,091

Title:	Matrix for sustained, invariant and independent release of active compounds
Abstract:	The invention concerns a storage stable pharmaceutical formulation comprising preferably two active compounds in a non-swellable diffusion matrix, whereby the compounds are released from the matrix in a sustained, invariant and, if several compounds are present, independent manner and the matrix is determined with respect to its substantial release characteristics by ethylcellulose and at least one fatty alcohol. The invention also concerns methods for producing such pharmaceutical formulations.
Inventor(s):	Brogmann; Bianca (Ulm, DE), Muhlah; Silke (Biberach, DE), Spitzley; Christof (Elbtal, DE)
Assignee:	Euro-Celtique S.A. (Luxembourg, LU)
Application Number:	14/058,108
Patent Claim Types: see list of patent claims	Formulation; Compound; Dosage form;

Drugs Protected by US Patent 8,846,091

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 8,846,091

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	102 15 067	Apr 5, 2002
Germany	102 15 131	Apr 5, 2002

International Family Members for US Patent 8,846,091

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
African Regional IP Organization (ARIPO)	2043
African Regional IP Organization (ARIPO)	2397
Argentina	039378